Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer With Brain Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT04767828
What this trial is testing

A Single Arm Study of Brain Metastasis in Patients With HER2-positive Breast Cancer

Who this might be right for
TTP
Tianjin Medical University Cancer Institute and Hospital 43
Testing effectiveness (Phase 2)Ended earlyNCT02669914
What this trial is testing

MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors

Who this might be right for
Non-Small Cell Lung CancerNonsmall Cell Lung CancerBreast Cancer+15 more
Washington University School of Medicine 4
Not applicableActive Not RecruitingNCT05703269
What this trial is testing

Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy

Who this might be right for
NSCLCRenal Cell CarcinomaBreast Carcinoma+5 more
Wake Forest University Health Sciences 58
Testing effectiveness (Phase 2)Study completedNCT00450866
What this trial is testing

Epothilone B in Treating Patients With CNS Metastases From Breast Cancer

Who this might be right for
Breast CancerMetastatic Cancer
David Peereboom, MD 55
Testing effectiveness (Phase 2)Study completedNCT01332630
What this trial is testing

TPI 287 in Breast Cancer Metastatic to the Brain

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 24
Early research (Phase 1)UnknownNCT03638765
What this trial is testing

Dendritic Cell Therapy for Brain Metastases From Breast- or Lung Cancer

Who this might be right for
Brain MetastasesLung Cancer MetastaticBreast Cancer Metastatic
Northwest Biotherapeutics 24
Early research (Phase 1)Ended earlyNCT05553522
What this trial is testing

Tucatinib, Trastuzumab, and Capecitabine With SRS for Brain Metastases From HER-2 Positive Breast Cancer

Who this might be right for
Brain MetastasesHER2-positive Breast Cancer
Baptist Health South Florida 1
Testing effectiveness (Phase 2)Study completedNCT01305941
What this trial is testing

Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases

Who this might be right for
HER-2 Positive Breast Cancer
UNC Lineberger Comprehensive Cancer Center 32
Early research (Phase 1)Study completedNCT02135159
What this trial is testing

Patients With Brain Metastases From HER2-positive Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 36
Testing effectiveness (Phase 2)WithdrawnNCT03637868
What this trial is testing

Eribulin in Brain Metastases From HER2-negative Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Institut Paoli-Calmettes
Not applicableNot Yet RecruitingNCT06015113
What this trial is testing

Efficacy and Safety of Disitamab Vedotin Plus Pyrotinib or Naratinib in HER2-positive Breast Cancer Patients With Brain Metastasis

Who this might be right for
Breast Cancer
Xi'an International Medical Center Hospital 20
Testing effectiveness (Phase 2)UnknownNCT06598046
What this trial is testing

A Single-arm, Prospective Phase Ⅱ Clinical Study of Utidelone Combined with Capecitabine in the Treatment of Active Brain Metastasis of TNBC

Who this might be right for
Metastatic Breast Cancer
Henan Cancer Hospital 48
Testing effectiveness (Phase 2)WithdrawnNCT04856475
What this trial is testing

Evaluation of Neratinib for Treatment and Prevention of Subsequent CNS Event(s) in Patients With Brain Metastasis of Advanced HER2 Positive Breast Cancer

Who this might be right for
Breast CancerBrain Metastases
Jules Bordet Institute
Not applicableLooking for participantsNCT06839547
What this trial is testing

A Prospective, Multicenter, Observational Cohort Study to Evaluate the Efficacy and Safety of a Novel Anti-tumor Drug as a Radiosensitizer in Patients With Advanced Breast Cancer Brain Metastasis.

Who this might be right for
Advanced Breast Cancer Brain Metastasis
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT06048718
What this trial is testing

T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases

Who this might be right for
Breast CancerMetastatic Breast Cancer
MedSIR 28
Not applicableNot Yet RecruitingNCT07689721
What this trial is testing

CtDNA-Guided Intraventricular Therapy for CNS Malignancies

Who this might be right for
Leptomeningeal DiseaseGlioblastomaBrain Metastases+2 more
Alireza Mansouri 77
Testing effectiveness (Phase 2)Active Not RecruitingNCT04647916
What this trial is testing

Testing Sacituzumab Govitecan Therapy in Patients With HER2-Negative Breast Cancer and Brain Metastases

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Invasive Breast CarcinomaMetastatic HER2 Negative Breast Carcinoma+2 more
SWOG Cancer Research Network 44
Post-approval studies (Phase 4)WithdrawnNCT02000739
What this trial is testing

Genetically-informed Therapies for Patients With Metastatic Cancer

Who this might be right for
Metastatic Cancer
Dartmouth-Hitchcock Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT06764940
What this trial is testing

A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases

Who this might be right for
HER2-negative Breast Cancer Patients With Brain Metastases
Biostar Pharma, Inc. 120
Early research (Phase 1)Study completedNCT01921335
What this trial is testing

ARRY-380 + Trastuzuamab for Breast w/ Brain Mets

Who this might be right for
Brain Metastases From HER2 and Breast CancerAdvanced HER2-positive Breast Cancer
Dana-Farber Cancer Institute 41
Next Page